Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Bancroft

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Nature|June 12, 1997
Funding for malaria genome sequencingS L Hoffman, W H Bancroft, M Gottlieb, et al.
The Journal of Infectious Diseases|December 1, 1983
Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune statusR M Scott, K H Eckels, W H Bancroft, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1984
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cellsK H Eckels, R M Scott, W H Bancroft, et al.
The Journal of Infectious Diseases|October 1, 1988
Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuationB L Innis, K H Eckels, E Kraiselburd, et al.
Infection and Immunity|January 11, 1975
Hepatitis B antigen in saliva, urine, and stoolG R Irwin, A M Allen, W H Bancroft, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1982
Dengue-2 vaccine: infection of Aedes aegypti mosquitoes by feeding on viremic recipientsW H Bancroft, R M Scott, W E Brandt, et al.
The Journal of Infectious Diseases|April 1, 1986
Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell culturesL N Binn, W H Bancroft, S M Lemon, et al.
Laboratory Animal Science|February 1, 1987
Induced oral infection of the owl monkey (Aotus trivirgatus) with hepatitis A virusC J Trahan, J W LeDuc, E C Staley, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1990
Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humansC H Hoke, F J Malinoski, K H Eckels, et al.
The Journal of Infectious Diseases|June 1, 1984
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiersW H Bancroft, R M Scott, K H Eckels, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Nature|June 12, 1997
Funding for malaria genome sequencingS L Hoffman, W H Bancroft, M Gottlieb, et al.
The Journal of Infectious Diseases|December 1, 1983
Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune statusR M Scott, K H Eckels, W H Bancroft, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1984
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cellsK H Eckels, R M Scott, W H Bancroft, et al.
The Journal of Infectious Diseases|October 1, 1988
Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuationB L Innis, K H Eckels, E Kraiselburd, et al.
Infection and Immunity|January 11, 1975
Hepatitis B antigen in saliva, urine, and stoolG R Irwin, A M Allen, W H Bancroft, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1982
Dengue-2 vaccine: infection of Aedes aegypti mosquitoes by feeding on viremic recipientsW H Bancroft, R M Scott, W E Brandt, et al.
The Journal of Infectious Diseases|April 1, 1986
Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell culturesL N Binn, W H Bancroft, S M Lemon, et al.
Laboratory Animal Science|February 1, 1987
Induced oral infection of the owl monkey (Aotus trivirgatus) with hepatitis A virusC J Trahan, J W LeDuc, E C Staley, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1990
Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humansC H Hoke, F J Malinoski, K H Eckels, et al.
The Journal of Infectious Diseases|June 1, 1984
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiersW H Bancroft, R M Scott, K H Eckels, et al.
Pageof 8